Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haskell-Luevano

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 13, 2005
Modified melanocortin tetrapeptide Ac-His-dPhe-Arg-Trp-NH at the arginine side chain with ureas and thioureasC G Joseph, N B Sorensen, M S Wood, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel agouti-related-protein-based melanocortin-1 receptor antagonistR Thirumoorthy, J R Holder, R M Bauzo, et al.
Endocrinology|March 6, 1999
Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the ratC Haskell-Luevano, P Chen, C Li, et al.
Journal of Medicinal Chemistry|August 15, 1997
beta-Methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activityC Haskell-Luevano, K Toth, L Boteju, et al.
Journal of Medicinal Chemistry|May 23, 1997
Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptorsC Haskell-Luevano, G Nikiforovich, S D Sharma, et al.
Journal of Medicinal Chemistry|May 12, 1995
Design, synthesis, biology, and conformations of bicyclic alpha-melanotropin analoguesC Haskell-Luevano, M D Shenderovich, S D Sharma, et al.
Drug Design and Discovery|December 1, 1996
Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonistsC Haskell-Luevano, T K Sawyer, S Trumpp-Kallmeyer, et al.
Journal of Medicinal Chemistry|July 4, 1997
Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4RC Haskell-Luevano, S Hendrata, C North, et al.
Journal of Medicinal Chemistry|November 10, 1995
Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activitiesC Haskell-Luevano, L W Boteju, H Miwa, et al.
Journal of Medicinal Chemistry|September 27, 1996
The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptorsL W Boteju, G V Nikiforovich, C Haskell-Luevano, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 13, 2005
Modified melanocortin tetrapeptide Ac-His-dPhe-Arg-Trp-NH at the arginine side chain with ureas and thioureasC G Joseph, N B Sorensen, M S Wood, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel agouti-related-protein-based melanocortin-1 receptor antagonistR Thirumoorthy, J R Holder, R M Bauzo, et al.
Endocrinology|March 6, 1999
Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the ratC Haskell-Luevano, P Chen, C Li, et al.
Journal of Medicinal Chemistry|August 15, 1997
beta-Methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activityC Haskell-Luevano, K Toth, L Boteju, et al.
Journal of Medicinal Chemistry|May 23, 1997
Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptorsC Haskell-Luevano, G Nikiforovich, S D Sharma, et al.
Journal of Medicinal Chemistry|May 12, 1995
Design, synthesis, biology, and conformations of bicyclic alpha-melanotropin analoguesC Haskell-Luevano, M D Shenderovich, S D Sharma, et al.
Drug Design and Discovery|December 1, 1996
Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonistsC Haskell-Luevano, T K Sawyer, S Trumpp-Kallmeyer, et al.
Journal of Medicinal Chemistry|July 4, 1997
Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4RC Haskell-Luevano, S Hendrata, C North, et al.
Journal of Medicinal Chemistry|November 10, 1995
Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activitiesC Haskell-Luevano, L W Boteju, H Miwa, et al.
Journal of Medicinal Chemistry|September 27, 1996
The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptorsL W Boteju, G V Nikiforovich, C Haskell-Luevano, et al.
Pageof 4